484 filings
Page 10 of 25
8-K
CLSD
Clearside Biomedical Inc
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:16pm
4
CLSD
Clearside Biomedical Inc
3 Jun 20
Clearside Biomedical / Charles A. Deignan ownership change
4:43pm
EFFECT
CLSD
Clearside Biomedical Inc
26 May 20
Notice of effectiveness
12:15am
424B5
CLSD
Clearside Biomedical Inc
22 May 20
Prospectus supplement for primary offering
5:07pm
4
CLSD
Clearside Biomedical Inc
21 May 20
Clearside Biomedical / Nancy J Hutson ownership change
4:50pm
CORRESP
CLSD
Clearside Biomedical Inc
20 May 20
Correspondence with SEC
12:00am
S-3/A
CLSD
Clearside Biomedical Inc
Shelf registration (amended)
19 May 20
12:00am
CORRESP
CLSD
Clearside Biomedical Inc
18 May 20
Correspondence with SEC
12:00am
UPLOAD
CLSD
Clearside Biomedical Inc
14 May 20
Letter from SEC
12:00am
4
Lasezkay George M
13 May 20
Clearside Biomedical / GEORGE M LASEZKAY ownership change
4:15pm
S-8
CLSD
Clearside Biomedical Inc
8 May 20
Registration of securities for employees
5:11pm
S-3
CLSD
Clearside Biomedical Inc
Shelf registration
8 May 20
5:02pm
10-Q
2020 Q1
CLSD
Clearside Biomedical Inc
Quarterly report
8 May 20
4:47pm
8-K
CLSD
Clearside Biomedical Inc
8 May 20
Clearside Biomedical Announces First Quarter 2020 Financial Results
7:15am
DEFA14A
CLSD
Clearside Biomedical Inc
29 Apr 20
Additional proxy soliciting materials
7:02am
DEF 14A
CLSD
Clearside Biomedical Inc
Definitive proxy
29 Apr 20
7:00am
8-K
CLSD
Clearside Biomedical Inc
28 Apr 20
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
7:15am
4
Nancy J Hutson
23 Apr 20
Clearside Biomedical / Nancy J Hutson ownership change
4:58pm
3
Nancy J Hutson
23 Apr 20
Clearside Biomedical / Nancy J Hutson ownership change
4:57pm
8-K
CLSD
Clearside Biomedical Inc
22 Apr 20
Clearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors
7:15am